SB 75 - Currently, a health care provider shall not knowingly prescribe or administer cross-sex hormones or puberty-blocking drugs for the purpose of a gender transition for children. This provision of law does not apply to those children who were prescribed or administered such drugs prior to August 28, 2023.

This prohibition on the prescription of cross-sex hormones or puberty-blocking drugs to children shall expire on August 28, 2027. This act removes the expiration date. Additionally, the provision excluding those children already prescribed or administered the hormones or drugs prior to August 28, 2023, from the general prohibition on the prescription of cross-sex hormones or puberty-blocking drugs to children shall expire March 1, 2026.

This act is substantially similar to HB 1520 (2024), SB 726 (2024), SB 776 (2024), and SB 1185 (2024).

SARAH HASKINS

Statutes affected:
Introduced (0208S.01): 191.1720

---

Senate Committee Minutes:
SENATE COMMITTEE MINUTES Bill No.: SB 75
Sponsor: Hudson
Hearing Date: 2/11/2025


COMMITTEE: Families, Seniors and Health

CHAIRMAN: Carter

DATE REFERRED: 1/16/2025 DATE HEARING REQUESTED:



STAFF:
Sarah Haskins
Heidi Kolkmeyer
Dennis Rhodes
Blake Thompson


WITNESSES GIVING INFORMATION:
Amy Hammerman - National Council of Jewish Women St. Louis


WITNESSES FOR:
James Harris - Do No Harm Action
Lisa Pannett - ArmorVine
Timothy Faber
Guillermo Villa-Trueba - Missouri Catholic Conference
Chriss White - Liberty Link Missouri


WITNESSES AGAINST:
Christopher Lehman
Emilia Stauffer
Melisabeth Johnston
Kate Hopkins
Ben Greene
Nicholas Tatum
Dava-Leigh Brush - Missouri Equity Education Partnership
Keith Rose - The Center for Growing Justice
Susan Shelby
Michael Donovan - Southampton Community Healthcare
Katherine Daugherty
Katy Erler - PROMO
Sarah Bloch - PROMO
Sage Corah - American Civil Liberties Union of Missouri
Seana Guilliams
Cammie Storm
Cat Rose